PL
OXFD

Parkwood LLC’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Parkwood LLC’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,799
Closed -$215K – 417
2017
Q2 		$215K Buy
12,799
+1,465
+13% +$21.9K 0.03% 349
2017
Q1 		$176K Buy
+11,334
New +$162K 0.02% 469

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parkwood LLC's OXFD Position: Q3 2017 in Review

Parkwood LLC sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2017, closing a stake of 12,799 shares — an estimated $215K sold.

Parkwood LLC first reported a position in OXFD in Q1 2017 and held it in 2 quarters. The position peaked at $215K in Q2 2017. 79 funds tracked by Wall St. Rank hold OXFD as of Q3 2017.

  • Parkwood LLC reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Parkwood LLC sold 12,799 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2017, an estimated $215K.
  • Parkwood LLC first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 2 quarters.
  • Parkwood LLC's Oxford Immunotec Global PLC Ordinary Shares position peaked at $215K in Q2 2017.
  • 79 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2017.

Based on Parkwood LLC's 13F filing for Q3 2017, filed 1 Nov 2017.